dzuveo
laboratoire aguettant - sufentanil salt - verkir - svæfingarlyf - dzuveo is indicated for the management of acute moderate to severe pain in adult patients.
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - Ónæmiskerfið sera og mótefni, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
lamisil krem 10 mg/g
karo healthcare ab - terbinafinum hýdróklóríð - krem - 10 mg/g
metylfenidat actavis forðatafla 18 mg
actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 18 mg
terbinafin actavis tafla 250 mg
actavis group ptc ehf. - terbinafinum hýdróklóríð - tafla - 250 mg
felodipine alvogen (felodipin ratiopharm) forðatafla 2,5 mg
alvogen ehf. - felodipinum inn - forðatafla - 2,5 mg
bactroban smyrsli 20 mg/g
glaxosmithkline pharma a/s - mupirocinum inn - smyrsli - 20 mg/g
bactroban nasal nefsmyrsli 20 mg/g
glaxosmithkline pharma a/s - mupirocinum kalsíum - nefsmyrsli - 20 mg/g
enalapril/hydrochlorothiazide medical valley tafla 20/12,5 mg
medical valley invest ab - enalaprilum maleat - tafla - 20/12,5 mg
felodipine alvogen (felodipin ratiopharm) forðatafla 10 mg
alvogen ehf. - felodipinum inn - forðatafla - 10 mg